Journals / Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2020 / Cilt: 53 - Sayı: 2

PREDICTORS OF HOSPITALIZATION IN CHILDREN WITH INFECTIOUS MONONUCLEOSIS

ENFEKSİYÖZ MONONÜKLEOZLU ÇOCUKLARDA HASTANEYE YATIRMA BELİRTEÇLERİ

Pages
113–119
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Presence of fever, palatal petechiae, orexudative tonsillitis and higher levels of C-reactive protein atpresentation were associated with higher rates of hospitalizations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: Infectious mononucleosis (IM), characterized by fever,lymphadenopathy and pharyngitis, is a common infectious diseasecaused by Epstein-Barr virus (EBV).
📊
Key Findings & Data:In this study, we performeda retrospective analysis of the clinical findings, laboratory dataand management of children with IM due to EBV to find out thepredictors of hospitalizations.MATERIAL AND METHODS: We retrospectively reviewed themedical records of patients under the age of 18 years who werediagnosed with IM between October 31, 2017 and October 31, 2018at Muğla Sıtkı Koçman University Medical Faculty Hospital.
💡
Conclusion & Impact:Presence of fever, palatal petechiae, orexudative tonsillitis and higher levels of C-reactive protein atpresentation were associated with higher rates of hospitalizations.
🔬Design:Review & Systematic Survey
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

AIM: Infectious mononucleosis (IM), characterized by fever,lymphadenopathy and pharyngitis, is a common infectious diseasecaused by Epstein-Barr virus (EBV). In this study, we performeda retrospective analysis of the clinical findings, laboratory dataand management of children with IM due to EBV to find out thepredictors of hospitalizations.MATERIAL AND METHODS: We retrospectively reviewed themedical records of patients under the age of 18 years who werediagnosed with IM between October 31, 2017 and October 31, 2018at Muğla Sıtkı Koçman University Medical Faculty Hospital. Thestudy population was categorized into three groups according tothe age; the 0-4 years, 5-10 years, and above 10 years. Complaints,physical examination findings, laboratory data, complicationsand treatment strategies of the patients were compared in thesegroups. Factors associated with hospitalizations and predictors ofhospitalization were also investigated.RESULTS: This study included 158 patients. The mean age of thepatients was 88.9 ± 53.5 months and 93 (58.9%) were male. Themost common complaint was fever (57.6%), and the most commonphysical examination finding was hepatomegaly (73.4%). Exceptfor fever, rash, thrombocytopenia and AST elevation, no significantdifference was found between the age groups and the clinical andlaboratory findings. Antibiotic therapy was applied to 44% of thepatients and 34.8% were hospitalized.Patients who needed hospitalization were more symptomatic, hadmore physical examination findings and had higher acute phasereactants. Presence of fever, palatal petechiae, or exudative tonsillitisand higher levels of C-reactive protein at presentation were found tobe significant predictors of hospitalizationCONCLUSIONS: More than one third of the children with IMrequired hospitalization. Presence of fever, palatal petechiae, orexudative tonsillitis and higher levels of C-reactive protein atpresentation were associated with higher rates of hospitalizations.

Özet

GİRİŞ: Ateş, lenfadenopati ve farenjit ile karakterize olan enfeksiyöz mononükleoz (IM), Epstein-Barr virüsünün (EBV) neden olduğu yaygın bir bulaşıcı hastalıktır. Bu çalışmada, EBV nedenli IM’li çocukların hastaneye yatış belirteçlerini belirlemek için klinik bulgular, laboratuvar veriler ve yönetimler geriye dönük olarak incelendi. GEREÇ VE YÖNTEMLER: Muğla Sıtkı Koçman Üniversitesi Tıp Fakültesi Hastanesi'nde 31 Ekim 2017 - 31 Ekim 2018 tarihleri arasında, İM tanısı alan 18 yaş altındaki hastaların tıbbi kayıtları geriye dönük olarak incelendi. Çalışma popülasyonu, 0-4 yaş, 5-10 yaş ve 10 yaş üstü olmak üzere 3 gruba ayrıldı. Hastaların şikayet, fizik muayene bulguları, laboratuvar verileri, komplikasyonları ve tedavi stratejileri bu gruplarda karşılaştırıldı. Hastaneye yatışla ilişkili faktörler ve hastaneye yatışın belirteçleri de incelenmiştir. BULGULAR: Çalışmaya 158 hasta dahil edildi. Hastaların yaş ortalaması 88,9 ± 53,5 ay ve 93'ü (% 58,9) erkek idi. En sık görülen şikayet ateş (% 57,6), en sık görülen fizik muayene bulgusu hepatomegali (% 73,4) idi. Ateş, döküntü, trombositopeni ve AST artışının dışında, klinik ve laboratuvar bulguları ile yaş grupları arasında anlamlı bir fark bulunmadı. Hastaların % 44'üne antibiyotik tedavisi uygulandı ve hastaların % 34,8'i hastanede yatarak tedavi gördü. Hastaneye yatırılan hastaların daha fazla semptom ve fizik muayene bulgularına, daha yüksek akut faz reaktanlarına sahip oldukları saptandı. Hastaneye yatış için önemli olduğu saptanan değişkenler ateş, damakta peteşi veya eksudatif tonsillit varlığı ve başvuruda yüksek C-reaktif protein seviyeleri idi. SONUÇLAR: Enfeksiyöz mononükleozlu çocukların üçte birinden fazlası hastanede yattırılarak tedavi gördü. Ateş, palatal peteşi veya eksüdatif tonsillit varlığı ve başvuru sırasında yüksek C-reaktif protein düzeyleri daha yüksek hastaneye yatış oranları ile ilişkilendirildi.

🔖

Cite This Article

TOPAL, Y., TOPAL, H., İNANÇ, B. B. (2022). PREDICTORS OF HOSPITALIZATION IN CHILDREN WITH INFECTIOUS MONONUCLEOSIS. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 53 - Sayı: 2, 113–119. https://ajindex.com/articles/441241

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. )Odumade OA, Hogquist KA, Balfour HH Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev. 2011
  2. )American Academy of Pediatrics. Epstein-Barr virus infections. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31 th ed. Itasca, IL: American Academy of Pediatrics
  3. )Dunmire SK, Hogquist KA, Balfour HH. Infectious Mononucleosis. Curr Top Microbiol Immunol. 2015
  4. 390(Pt 1): 211-40. 4.)Rea TD, Russo JE, Katon W, et al. Prospective study of the natural history of infectious mononucleosis caused by EpsteinBarr virus. J Am Board Fam Practice 2001, 14:234–242. 5.)Yoda K, Sata T, Kurata T, et al. Oropharyngotonsillitis associated with nonprimary Epstein-Barr virus infection. Arch Otolaryngol Head Neck Surg. 2000
  5. )Hoagland RJ, Henson HM. Splenic rupture in infectious mononucleosis. Ann Intern Med 1957
  6. 1184–1191. 7.)Evans A, Niederman J. Epstein-Barr virus. In: Evans A (Ed). Viral infections of human epidemiology and control. New York: Plenum Publishing
  7. p.265 8.)Fidan İ, Yüksel S, İmir T. Değişik yaş gruplarında Epstein-Barr virus antikorlarının araştırılması. İnfeksiyon Dergisi. 2005
  8. 456 9.)Ozkan A, Kilic SS, Kalkan A, et al. Seropositivity of EpsteinBarr virus in Eastern Anatolian Region of Turkey. Asian Pac J Allergy Immunol. 2003
  9. 49–53. 10.)Kalinyak KA. Anemias and other disorders of red blood cells. In: Osborn LM, DeWitt TG, First LR, Zenel JA (eds). Pediatrics. Philadelphia: Elsevier Mosby
  10. p. 686-92. 11.)Fu P. Presentation and initial evaluation of disorders of white blood cells. In: Osborn LM, DeWitt TG, First LR, Zenel JA (eds). Pediatrics. Philadelphia: Elsevier Mosby
  11. p. 693-7 12.)Hocqueloux L, Causse X, Valery A, et al. The high burden of hospitalization for primary EBV infection: a 6 year prospective survey in a French hospital. Clin Microbiol Infect. 2015
  12. )Horwitz CA, Henle W, Henle G, et al. Clinical and laboratory evaluation of infants and children with Epstein-Barr virusinduced infectious mononucleosis: report of 32 patients (aged 10- 48 months). Blood.1981
  13. )Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010
  14. 19932000. 15.)Jiao F, Yan X, Yan X, et al. Clinical analysis of 102 cases of Epstein-Barr virus infections in Chinese children. Georgian Med News. 2014
  15. :35-8. 16.)Kanegane H, Kanegane C, Y